As of March 2025 Catalyst Pharmaceuticals has a market cap of C$4.36 Billion. This makes Catalyst Pharmaceuticals the world's 3494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$4.36 B | 18.89% |
2024 | C$3.67 B | 54.59% |
2023 | C$2.37 B | -9.51% |
2022 | C$2.62 B | 195.59% |
2021 | C$0.88 B | 101.05% |
2020 | C$0.44 B | -12.72% |
2019 | C$0.50 B | 88.46% |
2018 | C$0.26 B | -46.66% |
2017 | C$0.50 B | 330.66% |
2016 | C$0.11 B | -58.46% |
2015 | C$0.28 B | 18.2% |
2014 | C$0.23 B | 112.01% |
2013 | C$0.11 B | 527.15% |
2012 | C$17.91 M | -44.72% |
2011 | C$32.41 M | 68.88% |
2010 | C$19.19 M | 60.51% |
2009 | C$11.95 M | -61.14% |
2008 | C$30.77 M | -28.63% |
2007 | C$43.11 M | -38.74% |
2006 | C$70.38 M |
On Mar 26th, 2025 the market cap of Catalyst Pharmaceuticals was reported to be: